hotspot -WSS

hotspot

author：focus 2025-10-01 14:14:46 - browse：13

Adam's take main illustration — Molly Ferguson/STAT

Cytokinetics was founded 26 years ago but has not yet developed a drug successfully to approval. That makes Tuesday’s Food and Drug Administration decision on its treatment for heart failure a big deal — except nearly everyone, even investors who own Cytokinetics — hopes the agency rules against it.

Hoping the FDA rejects the Cytokinetics drug, called omecamtiv mecarbil, is a relatively uncommon, up-is-down, down-is-up situation, but it makes sense in this case because the business and science of the drug are not aligned.

Consider: Cytokinetics shares rose in December when an outside group of experts convened by the FDA to examine omecamtiv’s benefits and risks recommended against the medicine’s approval. On Tuesday, the FDA is most likely to heed that advice and turn down the company’s marketing application.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： CDC launches VaccineFinder tool to locate Covid

WSS

Travel bans should be based on evidence, not politics or fear

Choosing scientific sides in the fight against Alzheimer's

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Lessons Learned: This is why you network to find that industry job you want

The painfully weak evidence on taking collagen to treat arthritis

Sage's campaign to raise awareness of postpartum depression hits a nerve

hotspot

hotspot

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Duchenne breakthrough therapy leaves behind pioneering families

Former Georgia lieutenant governor says he received grand jury subpoena

As demand for Covid shots wanes, Moderna seeks its next success

More regulation could be coming for drug ads

Hollywood unions extend contract negotiations for actors

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

Alkermes shareholders re

Judge rejects Trump's counterclaim against E. Jean Carroll

entertainment

Germany receives 178 compensation applications from gay servicepeople over discrimination

Germany receives 178 compensation applications from gay servicepeople over discrimination

More regulation could be coming for drug ads

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

Lessons Learned: This is why you network to find that industry job you want

The painfully weak evidence on taking collagen to treat arthritis

knowledge

focus

focus

focus